Cargando…
Regression of a glioblastoma multiforme: spontaneous versus a potential antineoplastic effect of dexamethasone and levetiracetam
Patients with grade IV astrocytoma or glioblastoma multiforme (GBM) have a median survival of <12 months, increased to 14.6 months by maximal safe resection with radiation and temozolamide. In the absence of chemotherapy, radiotherapy or chemoradiotherapy, spontaneous regression of GBM or regress...
Autores principales: | Peddi, Prakash, Ajit, Nisha Elizabeth, Burton, Gary Von, El-Osta, Hazem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237800/ https://www.ncbi.nlm.nih.gov/pubmed/28011886 http://dx.doi.org/10.1136/bcr-2016-217393 |
Ejemplares similares
-
Dexamethasone in Glioblastoma Multiforme Therapy: Mechanisms and Controversies
por: Cenciarini, Marta, et al.
Publicado: (2019) -
Immune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatment
por: El-Osta, Hazem, et al.
Publicado: (2016) -
Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012) -
Melatonin’s Antineoplastic Potential Against Glioblastoma
por: Moretti, Enrico, et al.
Publicado: (2020) -
Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)